Outcomes Following Delta Xtend Reverse Shoulder System

N/AUnknownNCT02014350

Rothman Institute Orthopaedics

Overview

To collect medium to long-term survivorship implant outcomes on the DePuy Delta Xtend Reverse Shoulder Stystem.

Study Type

OBSERVATIONAL

Conditions

Reverse Total Shoulder Arthroplasty

Interventions

DePuy Delta Xtend Reverse TSADEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Patients whom were implanted with the DePuy Delta Xtend Reverse Total Shoulder System in the time frame indicated. Patients must be willing to sign the consent form and complete all follow-up visits.

Locations (1)

Rothman Institute

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Implant Survivorship

Time frame: 10 years post-operative

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.